Please login to the form below

Not currently logged in
Email:
Password:

women's health

This page shows the latest women's health news and features for those working in and with pharma, biotech and healthcare.

Merck & Co’s sales bounce back in ‘ongoing recovery from COVID-19’

Merck & Co’s sales bounce back in ‘ongoing recovery from COVID-19’

Merck’s president of human health also highlighted positive impact from “outside the United States, [where] growth was driven by increased demand in China”. ... In June, Merck completed the spin-off of women’s health company Organon, freeing up

Latest news

  • Merck & Co spinoff Organon launches with the aim of 'improving health outcomes for women' Merck & Co spinoff Organon launches with the aim of 'improving health outcomes for women'

    Merck &Co – known as MSD outside the US and Canada – announced its plans for the women’s health spinoff company last month. ... Organon’s portfolio contains over 60 medicines and products across three core franchises at launch – women’s health

  • Merck & Co reveals plans for women’s health spinoff Organon Merck & Co reveals plans for womens health spinoff Organon

    Organon’s portfolio will contain over 60 medicines and products across three core franchises at launch – women’s health, biosimilars and established brands. ... Organon, as a standalone company, will be better positioned to realise its potential

  • Q&A: Kay Wesley Q&A: Kay Wesley

    PME chats to the Chief Executive of Kanga Health Ltd and Town Councillor at Women’s Equality Party Congleton. ... Kay Wesley is Chief Executive of Kanga Health Ltd and Town Councillor at Women’s Equality Party Congleton.

  • GSK considers more divestments to help R&D push GSK considers more divestments to help R&D push

    consumer health joint venture with Pfizer as it steps up its spend on R&D. ... slower-growing, mature products into a standalone company focusing on generics and women’s health products.

  • Merck spins off low-growth drugs in a ‘purposeful shift’ of focus Merck spins off low-growth drugs in a ‘purposeful shift’ of focus

    The NewCo will be led by Kevin Ali, a long-time Merck veteran, who will oversee the spinoff of Merck’s women’s health, legacy brands and biosimilar products. ... The combined value of these products total around 15% of Merck’s human health revenues

More from news
Approximately 8 fully matching, plus 93 partially matching documents found.

Latest Intelligence

  • Case study: Project Family Case study: Project Family

    In spite of persistent myths, fertility is not just a women’s issue. ... We are now not only being recognised as leaders in reproductive medicine and women’s health, but our bold approach to external communications has got people talking about these

  • AI’s role in pharma marketing AI’s role in pharma marketing

    Our client had a compelling message to share about treatment options for its women’s health therapy, yet had limited visibility into the HCP population for whom this message would be ... The natural question was: ‘Which HCPs have an interest in

  • Deal Watch October 2018

    acquisition. In a third, widely reported rumour, Pfizer is said to be looking at divesting its women’s health division, which includes the product Premarin for the menopause. ... Given that Teva divested its women’s health division for $1.38B earlier

  • Advancing women in healthcare Advancing women in healthcare

    This theme was picked up in the HBA’s meeting in London, with a roundtable of women healthcare leaders hosted at Syneos Health by the President of Syneos Health Communications Europe, ... Dr Priya Agrawal is Business Unit Director, Vaccines &Women’s

  • If you’re going global, go local and go early If you’re going global, go local and go early

    Similarly, the inspiration for a recent global women’s cancer campaign originated from work with colleagues based in the Middle East - an area that might be considered an unconventional source for ... strategic and creative insights on women’s health

More from intelligence
Approximately 0 fully matching, plus 25 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 18 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 5 fully matching, plus 34 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
W2O Group

W2O Group is an integrated marketing agency with expertise in brand and digital strategy, creative development and communications services. We...

Latest intelligence

Diversity in clinical trials: looking back at our 2021 blogs
In this blog, we look back at the Innovative Trials' Equality & Diversity (E&D) committee blogs across 2021...
What does the future hold for Light-chain Amyloidosis?
Recent advances in the understanding and treatment are reforming pharma’s approach to the management of this rare disease. With a new standard of care rapidly developing, what does the landscape...
Webinar:
Securing a future for telehealth with immersive market research insights...